ArticleFrontiers in oncology2023

Therapeutic drug monitoring guided dosing versus standard dosing of alectinib in advanced ALK positive non-small cell lung cancer patients: Study protocol for an international, multicenter phase IV randomized controlled trial (ADAPT ALEC).

Marinda Meertens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.